Singular Health Group (ASX:SHG) - Advisor, Jonathan Clark
Advisor, Jonathan Clark
Source: Chris O’Brien Lifehouse
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Leading surgeon Jonathan Clark will join Singular Health Group’s (SHG) newly formed advisory board
  • The medical technology company is creating a panel of specialists to help integrate its software into medical workflows
  • Its first appointee brings more 20 years of clinical experience to the role, with positions at Sydney’s Royal Prince Alfred Hospital and Chris O’Brien Lifehouse
  • SHG says the appointment of Professor Clark is a win for the company as it continues to develop its end-to-end software solution, Scan to Surgery
  • Shares in Singular Health Group are treading up 5 per cent at 21 cents at 10:55 am AEST

Leading surgeon Jonathan Clark will join Singular Health Group’s (SHG) newly-formed advisory board.

The medical technology company announced the appointment on Thursday, revealing it plans to create a panel of world-class clinicians and specialists.

SHG wants the board to help guide its strategy around surgeon engagement and hospital outreach as it looks to integrate its software solutions into standard medical workflows.

Singular Health is focused on the development its end-to-end software solution for secure patient and practitioner data sharing, called the Scan to Surgery Initiative.

The company’s first appointment, Professor Clark, will bring more than 20 years’ clinical experience to the role, with positions at the Chris O’Brien Lifehouse and Royal Prince Alfred Hospital.

He also leads head and neck cancer research at the Sydney Head and Neck Cancer Institute and is a research lead at the Royal Prince Alfred Institute of Academic Surgery.

Commenting on the appointment, SHG CEO Thomas Hanly said Professor Clark’s appointment was an incredible win for the company.

“I’m exceptionally pleased to announce the formation of our advisory board and to welcome Professor Jonathan Clark as our first Advisory Board Member,” Mr Hanly said.

“His reputation in the patient-specific reconstructive surgical space is second to none and we look forward to applying his unique insights and clinical experience to the product development and commercialisation of our Scan to Surgery initiative.”

Professor Clark, who was awarded a Member of the Order Of Australia in 2019, said he was excited to be partnering with SHG as it continued to advance Scan to Surgery.

“This is an exciting opportunity to work with Singular Health in the area of digital planning for surgical applications,” he said.

“I believe that Scan to Surgery has the potential to revolutionise the interaction between surgeons, planning software and design engineers by incorporating VR and streamlining the segmentation of DICOM data from CT images.”

As part of the appointment, SHG will issue Professor Clark 250,000 unlisted options with an exercise price of 30 cents and an expiry of date of three years.

Shares in Singular Health Group were treading up 5 per cent at 21 cents at 10:55 am AEST.

SHG by the numbers
More From The Market Online

Inoviq closes the gap on blood test results for ovarian cancer

INOVIQ has announced encouraging blood test identification results for ovarian cancer – cancer-positive tests saw a…

Paradigm Biopharma on track to US Phase III osteo program

Paradigm Biopharma has announced its completion of a submission to the US FDA to progress to…

Firebrick Pharma’s US launch of Nasal Spray is nothing to be sneezed at

Australian pharmaceutical developer, Firebrick Pharma (ASX:FRE) has launched its latest product, Nasodine Nasal Spray, in the…